Clinical Trial Update: Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter 4 [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the Crux Inferior Vena Cava Filter 4 for pulmonary embolism; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Crux Inferior Vena Cava Filter 4

Snippet

Sponsor: Crux Biomedical | Conditions: Pulmonary Embolism | Phase 3 | Status: COMPLETED